Judge Rebuffs Actavis Attempt to Limit Discovery in Suit

Actavis Totowa has failed to stop plaintiffs in a class action suit from expanding the scope of discovery at its Little Falls, N.J., plant. The suit is related to the April 2008 Class I nationwide recall of its heart drug Digitek. The litigation was brought after the commercial release of tablets that might have contained twice the approved level of active ingredient, posing a risk of digitalis toxicity in patients with renal failure. As a result, consumers of the drug filed failure-to-warn suits, which allege that Actavis didn’t warn the public of the effects of potentially outsized Digitek tablets in a timely fashion.
Generic Line